Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs UDR Inc. Common Stock (UDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs UDR Inc. Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: UDR Inc. Common Stock is far larger — about 2.1× Oruka Therapeutics Inc. Common Stock's market cap, and UDR Inc. Common Stock pays a 5.12% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and UDR Inc. Common Stock for 0 Days on average.
| ORKA | UDR | |
|---|---|---|
Market Cap | $5.18B | $10.93B |
Volume | 490,798 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $113.08 | $41.24 |
52-Week Low | $26.19 | $33.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $16.96B |
Dividend Yield | — | 5.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →
